Perchlorate Information Bureau |
|||||||||||||
|
|||||||||||||
|
|||||||||||||
Woods Hole, MA - New research on the effects of perchlorate on pregnant women, infants and adults was presented to a special panel of the National Academy of Sciences (NAS) yesterday, with preliminary findings suggesting that perchlorate levels ranging from non-detect to 110 parts per billion (ppb) have no effect on pregnant women and infants, and that perchlorate with levels as high as 10,000 ppb has no effect on healthy adults. The preliminary findings were presented by John Gibbs, M.D., vice president of Health Management and Corporate medical director, Kerr-McGee Corporation, and Jonathan Borak, M.D., Associate Clinical Professor of Medicine & Epidemiology, Yale University, working with the Perchlorate Information Bureau. Summaries of the reports are as follows:
The Perchlorate Information Bureau is supported by a subset of the member companies of the Perchlorate Information Bureau, including Lockheed Martin, Aerojet, Kerr-McGee Chemical and American Pacific Corporation. In the past decade, the Perchlorate Information Bureau has worked cooperatively with the U.S. Environmental Protection Agency to increase scientific and medical understanding of perchlorate's risk to human health. ### |
|||||||||||||
|
© 2009 Perchlorate Information Bureau: Web Site Terms and Conditions : Privacy Policy : Site Map : Contact Us |